Download PDF
Exp Clin Endocrinol Diabetes 2007; 115(4): 244-251
DOI: 10.1055/s-2007-956166
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG · Stuttgart · New York

Concerted Action of Leptin in Regulation of Fatty Acid Oxidation in Skeletal Muscle and Liver

S. Wein 1 [*] [**] , J. Ukropec 1 [*] , D. Gašperíková 1 , I. Klimeš 1 , E. Šeböková 1
  • 1Diabetes and Nutrition Research Laboratory, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic
Further Information

Publication History

Received 28. 7. 2006 first decision 15. 9. 2006

Accepted 4. 10. 2006

Publication Date:
03 May 2007 (online)

Also available at
    Permissions and Reprints

Abstract

Central action of leptin on food intake and energy expenditure is integrated with leptin's peripheral action modulating the fatty acid and glucose metabolism and preventing the accumulation of lipids in nonadipose tissues. However, exact mechanism(s) of the leptin's action in the peripheral tissues has not yet been fully elucidated. Therefore, we investigated the effect of a single intravenous injection of leptin on palmitoyl-CoA and palmitoyl-carnitine oxidation rate in liver and skeletal muscle followed by measurements of the carnitine-palmitoyl transferase 1 (CPT1) activity and activities of ß-oxidation enzymes in mitochondria (acyl-CoA dehydrogenase) and in peroxisomes (acyl-CoA oxidase) of rats. Animals were euthanized and tissues and serum harvested 15 min, 1 hour, 3 hours and 6 hours after leptin administration. Intravenous leptin injection increased mitochondrial palmitoyl-CoA oxidation rate in both liver (95%; P<0.025) and skeletal muscle (2.7-fold; P<0.05). This was paralleled by lowering hepatic (-156%; P<0.001) and skeletal muscle (-191%; P<0.001) triglyceride content. Leptin-induced elevation of palmitoyl-CoA oxidation rate in liver was paralleled by increased CPT1 activity (52%; P<0.05) and ß-oxidation capacity (52%; P<0.05). Lack of the leptin's effect on the CPT1-activity in muscle (20%; p=0.09) suggests the existence of an alternative pathway for increasing the palmitoyl-CoA-oxidation rate bypassing the CPT1 regulatory step. Interestingly, leptin stimulated the overall ß-oxidation capacity in muscle by 69% (P=0.027). This may indicate to an involvement of mitochondrial acyl-CoA dehydrogenases as well as of peroxisomal fat catabolism. Taken together, we showed that leptin acutely increases palmitoyl-CoA oxidation rate in liver and in skeletal muscle, which was associated with tissue specific effect on the CPT1 activity as well as on the downstream enzymes of fatty acid oxidation pathways in rat mitochondria and peroxisomes. Tangible evidence for the leptin-induced increase of fatty acid catabolism was provided by a lowered skeletal muscle and hepatic lipid deposition.

Key words

leptin - fatty acid oxidation - liver - skeletal muscle - lipids - carnitine palmitoyl transferase - rat

References

  • 1 Ahima RS, Flier JS. Leptin.  Ann Rev Physiol. 2000;  62 413-437
    CrossrefPubMedGoogle Scholar
  • 2 Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. Role of leptin in the neuroendocrine response to fasting.  Nature. 1996;  382 250-252
    CrossrefPubMedGoogle Scholar
  • 3 Barazzoni R, Zanetti M, Bosutti A, Biolo G, Vitali-Serdoz L, Stebel M, Guarnieri G. Moderate caloric restriction, but not physiological hyperleptinemia per se, enhances mitochondrial oxidative capacity in rat liver and skeletal muscle-tissue-specific impact on tissue triglyceride content and AKT activation.  Endocrinology. 2005;  146 2098-2106
    CrossrefPubMedGoogle Scholar
  • 4 Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery.  Recent Prog Horm Res. 2004;  59 305-331
    CrossrefPubMedGoogle Scholar
  • 5 Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification.  Can J Biochem Physiol. 1959;  37 911-917
    CrossrefPubMedGoogle Scholar
  • 6 Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway-a link between adipose tissue mass and central neural networks.  Horm Metab Res. 1996;  28 619-632
    PubMedGoogle Scholar
  • 7 Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin.  Science. 1996;  274 1185-1188
    CrossrefPubMedGoogle Scholar
  • 8 Considine RV. Regulation of leptin production.  Rev Endocr Metab Disord. 2001;  2 357-363
    CrossrefPubMedGoogle Scholar
  • 9 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL. et al . Serum immunoreactive-leptin concentrations in normal-weight and obese humans.  N Engl J Med. 1996;  334 292-295
    CrossrefPubMedGoogle Scholar
  • 10 Dyck DJ. Leptin sensitivity in skeletal muscle is modulated by diet and exercise.  Exerc Sport Sci Rev. 2005;  33 189-194
    CrossrefPubMedGoogle Scholar
  • 11 Eaton S. Control of mitochondrial β-oxidation flux.  Prog Lipid Res. 2002;  41 197-239
    PubMedGoogle Scholar
  • 12 Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals.  Nature. 1998;  395 763-770
    CrossrefPubMedGoogle Scholar
  • 13 Guzman M, Geelen MJ. Regulation of fatty acid oxidation in mammalian liver.  Biochim Biophys Acta. 1993;  1167 227-241
    PubMedGoogle Scholar
  • 14 Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene.  Science. 1995;  269 543-546
    CrossrefPubMedGoogle Scholar
  • 15 Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?.  Annu Rev Biochem. 1998;  67 821-855
    CrossrefPubMedGoogle Scholar
  • 16 Hashimoto T. Peroxisomal β-oxidation: enzymology and molecular biology.  Ann N Y Acad Sci. 1996;  804 86-98
    CrossrefPubMedGoogle Scholar
  • 17 Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, Pories WJ, MacDonald KG, Cline GW, Shulman GI, Dohm GL, Houmard JA. Skeletal muscle lipid metabolism with obesity.  Am J Physiol Endocrinol Metab. 2003;  284 E741-747
    PubMedGoogle Scholar
  • 18 Jequier E. Leptin signaling, adiposity, and energy balance.  Ann N Y Acad Sci. 2002;  967 379-388
    PubMedGoogle Scholar
  • 19 Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment.  Nature. 1997;  389 374-377
    CrossrefPubMedGoogle Scholar
  • 20 Koves TR, Noland RC, Bates AL, Henes ST, Muoio DM, Cortright RN. Subsarcolemmal and intermyofibrillar mitochondria play distinct roles in regulating skeletal muscle fatty acid metabolism.  Am J Physiol Cell Physiol. 2005;  288 C1074-1082
    CrossrefPubMedGoogle Scholar
  • 21 Kunau WH, Dommes V, Schulz H. β-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: a century of continued progress.  Prog Lipid Res. 1995;  34 267-342
    PubMedGoogle Scholar
  • 22 Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM. Abnormal splicing of the leptin receptor in diabetic mice.  Nature. 1996;  379 632-635
    CrossrefPubMedGoogle Scholar
  • 23 Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation.  J Clin Invest. 2006;  116 1776-1783
    CrossrefPubMedGoogle Scholar
  • 24 McGarry JD. Travels with carnitine palmitoyltransferase I: from liver to germ cell with stops in between.  Biochem Soc Trans. 2001;  29 ((Pt 2)) 241-245
    CrossrefPubMedGoogle Scholar
  • 25 McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.  Eur J Biochem. 1997;  244 1-14
    CrossrefPubMedGoogle Scholar
  • 26 McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production.  Annu Rev Biochem. 1980;  49 395-420
    CrossrefPubMedGoogle Scholar
  • 27 McGarry JD, Mills SE, Long CS, Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in nonhepatic tissues of the rat.  Biochem J. 1983;  214 21-28
    PubMedGoogle Scholar
  • 28 Minokoshi Y, Kahn BB. Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle.  Biochem Soc Trans. 2003;  31 ((Pt 1)) 196-201
    PubMedGoogle Scholar
  • 29 Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.  Nature. 2002;  415 339-343
    CrossrefPubMedGoogle Scholar
  • 30 Muoio DM, Dohm GL, Fiedorek Jr FT, Tapscott EB, Coleman RA. Leptin directly alters lipid partitioning in skeletal muscle.  Diabetes. 1997;  46 1360-1363
    PubMedGoogle Scholar
  • 31 Muoio DM, Newgard CB. Obesity-related derangements in metabolic regulation.  Annu Rev Biochem. 2006;  75 367-401
    CrossrefPubMedGoogle Scholar
  • 32 Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice.  Science. 1995;  269 540-543
    CrossrefPubMedGoogle Scholar
  • 33 Roepstorff C, Vistisen B, Kiens B. Intramuscular triacylglycerol in energy metabolism during exercise in humans.  Exerc Sport Sci Rev. 2005;  33 182-188
    CrossrefPubMedGoogle Scholar
  • 34 Rossetti L, Massillon D, Barzilai N, Vuguin P, Chen W, Hawkins M, Wu J, Wang J. Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action.  J Biol Chem. 1997;  272 27758-27763
    CrossrefPubMedGoogle Scholar
  • 35 Saggerson ED, Carpenter CA. Carnitine palmitoyltransferase and carnitine octanoyltransferase activities in liver, kidney cortex, adipocyte, lactating mammary gland, skeletal muscle and heart.  FEBS Lett. 1981;  129 229-232
    CrossrefPubMedGoogle Scholar
  • 36 Seufert J. Leptin effects on pancreatic β-cell gene expression and function.  Diabetes. 2004;  53 ((Suppl 1)) S152-158
    CrossrefPubMedGoogle Scholar
  • 37 Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH. Direct antidiabetic effect of leptin through triglyceride depletion of tissues.  Proc Natl Acad Sci USA. 1997;  94 4637-4641
    CrossrefPubMedGoogle Scholar
  • 38 Shulman GI. Cellular mechanisms of insulin resistance.  J Clin Invest. 2000;  106 171-176
    CrossrefPubMedGoogle Scholar
  • 39 Scholte HR, Yu Y, Ross JD, Oosterkamp II, Boonman AM, Busch HF. Rapid isolation of muscle and heart mitochondria, the lability of oxidative phosphorylation and attempts to stabilize the process in vitro by taurine, carnitine and other compounds.  Mol Cell Biochem. 1997;  174 61-66
    CrossrefPubMedGoogle Scholar
  • 40 Souri M, Aoyama T, Hashimoto T. A sensitive assay of acyl-coenzyme. A oxidase by coupling with β-oxidation multienzyme complex.  Anal Biochem. 1994;  221 362-367
    CrossrefPubMedGoogle Scholar
  • 41 Tanaka T, Hidaka S, Masuzaki H, Yasue S, Minokoshi Y, Ebihara K, Chusho H, Ogawa Y, Toyoda T, Sato K, Miyanaga F, Fujimoto M, Tomita T, Kusakabe T, Kobayashi N, Tanioka H, Hayashi T, Hosoda K, Yoshimatsu H, Sakata T, Nakao K. Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification.  Diabetes. 2005;  54 2365-2374
    CrossrefPubMedGoogle Scholar
  • 42 Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R.  Cell. 1995;  83 1263-1271
    CrossrefPubMedGoogle Scholar
  • 43 Trayhurn P. Leptin-a critical body weight signal and a “master” hormone?.  Sci STKE. 2003;  PE7
    PubMedGoogle Scholar
  • 44 Uchiyama A, Aoyama T, Kamijo K, Uchida Y, Kondo N, Orii T, Hashimoto T. Molecular cloning of cDNA encoding rat very long-chain acyl-CoA synthetase.  J Biol Chem. 1996;  271 30360-30365
    CrossrefPubMedGoogle Scholar
  • 45 Ukropec J, Anunciado RV, Ravussin Y, Kozak LP. Leptin is required for UCP1-independent thermogenesis during cold stress.  Endocrinology. 2006;  147 2468-2480
    CrossrefPubMedGoogle Scholar
  • 46 Ukropec J, Reseland JE, Gasperikova D, Demcakova E, Madsen L, Berge RK, Rustan AC, Klimes I, Drevon CA, Sebokova E. The hypotriglyceridemic effect of dietary n-3 FA is associated with increased β-oxidation and reduced leptin expression.  Lipids. 2003;  38 1023-1029
    PubMedGoogle Scholar
  • 47 Ukropec J, Sebokova E, Klimes I. Nutrient sensing, leptin and insulin action.  Arch Physiol Biochem. 2001;  109 38-51
    CrossrefPubMedGoogle Scholar
  • 48 Unger RH. Lipotoxic diseases.  Annu Rev Med. 2002;  53 319-336
    CrossrefPubMedGoogle Scholar
  • 49 Unger RH. Hyperleptinemia: protecting the heart from lipid overload.  Hypertension. 2005;  45 1031-1034
    CrossrefPubMedGoogle Scholar
  • 50 Vaisse C, Halaas JL, Horvath CM, Darnell Jr JE, Stoffel M, Friedman JM. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice.  Nat Genet. 1996;  14 95-97
    CrossrefPubMedGoogle Scholar
  • 51 Wang ZW, Pan WT, Lee Y, Kakuma T, Zhou YT, Unger RH. The role of leptin resistance in the lipid abnormalities of aging.  Faseb J. 2001;  15 108-114
    CrossrefPubMedGoogle Scholar
  • 52 Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.  Am J Physiol. 1999;  277 ((1 Pt 1)) E1-10
    PubMedGoogle Scholar
  • 53 Zammit VA. The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function.  Biochem J. 1999;  343 ((Pt 3)) 505-515
    CrossrefPubMedGoogle Scholar

1 First two authors SW and JU contributed equally to this work.

2 Current address of author, Institute of Animal Nutrition & Physiology, Christian-Albrechts-University of Kiel, Herrmann-Rodewald-Str. 9, 24098 Kiel, Germany
Email: wein@aninut.uni-kiel.de

Correspondence

J. UkropecPhD 

Inst. Exp. Endocrinology SAS

Vlárska Str. 3

SK-83306 Bratislava

Slovakia

Phone: +421/2/54 77 28 00

Fax: +421/2/54 77 26 87

Email: jozef.ukropec@savba.sk